Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

During Switzerland’s first wave of COVID-19, clinical pharmacy activities during medical rounds in Geneva University Hospitals were replaced by targeted remote interventions. We describe using the electronic PharmaCheck system to screen high-risk situations of adverse drug events (ADEs), particularl...

Descripción completa

Detalles Bibliográficos
Autores principales: Skalafouris, Christian, Samer, Caroline, Stirnemann, Jerome, Grosgurin, Olivier, Eggimann, François, Grauser, Damien, Reny, Jean-Luc, Bonnabry, Pascal, Guignard, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986913/
https://www.ncbi.nlm.nih.gov/pubmed/33832918
http://dx.doi.org/10.1136/ejhpharm-2020-002667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986913/
https://www.ncbi.nlm.nih.gov/pubmed/33832918
http://dx.doi.org/10.1136/ejhpharm-2020-002667

Ejemplares similares